Myriad(MYGN) - 2025 Q4 - Annual Results

Testing Volume Projections - Myriad Genetics, Inc. expects total test volumes in 2025 to be approximately 1.5 million, reflecting a 1% year-over-year increase[4] - The company anticipates a 7% year-over-year growth in hereditary cancer testing volume for 2025[4] - Mental health testing volume is projected to grow by approximately 6% year-over-year in 2025[4] - Prenatal health testing volume is expected to decrease by approximately 4% year-over-year in 2025[4] Financial Guidance - Myriad Genetics, Inc. introduced full year 2026 financial guidance alongside the preliminary revenue announcement[4]